Latest news with #AmericanSemiconductor
Yahoo
29-07-2025
- Business
- Yahoo
Metagenomi (MGX) Presents Latest in Gene Editing Technologies
Metagenomi, Inc. (NASDAQ:MGX) is one of the 11 Best New Penny Stocks to Buy Right Now. On May 14, Metagenomi, Inc. (NASDAQ:MGX) announced that it is presenting three abstracts at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting, held from May 13 to 17, 2025, in New Orleans, Louisiana. These presentations highlighted Metagenomi, Inc.'s (NASDAQ:MGX) advancements in compact nucleases for extrahepatic gene editing and CAST (CRISPR-associated transposases) for site-specific integration of large therapeutic genes. A lab scientist peering into a microscope focused on gene editing technology. The company's special metagenomics discovery platform can systematically identify and optimize novel gene editing systems through natural microbial evolution and AI-guided protein optimization. At the meeting, Metagenomi, Inc. (NASDAQ:MGX) shared early proof-of-concept data across different types of gene-editing technologies. This included compact Type II and Type V nucleases for efficient in vivo editing and a programmable Type V-K CAST system capable of targeted integration of large DNA cargoes. The small nucleases can potentially improve delivery to hard-to-reach tissues, while CAST offers promising new tools for targeted and precise large gene integration, addressing one of the greatest challenges in gene editing. Metagenomi, Inc.'s (NASDAQ:MGX) work shows promise in specifically integrating correct copies of complete genes, which could enable treatment for diseases caused by a loss-of-function mutation. Metagenomi, Inc. (NASDAQ:MGX) is a precision gene editing company focused on developing curative therapeutics using its proprietary, metagenomics-derived genome editing toolbox. While we acknowledge the potential of MGX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-07-2025
- Business
- Yahoo
Mizuho Raises Price Target for Neumora (NMRA), Keeps Outperform Rating
Neumora Therapeutics, Inc. (NASDAQ:NMRA) is one of the 11 Best New Penny Stocks to Buy Right Now. On July 16, Mizuho increased its price target for Neumora Therapeutics, Inc. (NASDAQ:NMRA) from $4 to $5 and kept an 'Outperform' rating. This decision came after Neumora Therapeutics, Inc. (NASDAQ:NMRA) introduced NMRA-861, which is a strong and selective positive allosteric modulator (PAM) of the M4 muscarinic receptor. The company is developing NMRA-861 for the treatment of schizophrenia and other neuropsychiatric disorders. A doctor examining a patient's brain scan in a hospital setting displaying a neurological disorder. Mizuho expects NMRA-861 to be launched in the US in 2034 with risk-unadjusted sales reaching $1.2 billion by 2037. This supports the firm's decision to increase the price target. The research firm also noted that even though Neumora Therapeutics, Inc. (NASDAQ:NMRA) trades at a negative enterprise value because of negative Phase 3 data for navacaprant in depression earlier this year, the company's pipeline is still very promising. Mizuho identified four distinct clinical catalysts for Neumora Therapeutics, Inc. (NASDAQ:NMRA) expected over the next 12 months that could positively affect the stock price. The firm sees a good risk/reward balance for investing in the stock. Neumora Therapeutics, Inc. (NASDAQ:NMRA) is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing novel therapies for brain diseases. While we acknowledge the potential of NMRA as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-07-2025
- Business
- Yahoo
Canaccord Genuity Reiterates Buy Rating on Fractyl Health (GUTS)
Fractyl Health, Inc. (NASDAQ:GUTS) is one of the 11 Best New Penny Stocks to Buy Right Now. On July 18, Canaccord Genuity reiterated its 'Buy' rating on Fractyl Health, Inc. (NASDAQ:GUTS) with a price target of $12. This decision came after the company had shared new data from its Phase 3 trial of its lead product candidate, Revita. A medical laboratory surrounded by advanced equipment, symbolizing the company's cutting-edge innovation in healthcare. Canaccord Genuity had follow-up discussions with several physicians following the data presented by Fractyl Health, Inc. (NASDAQ:GUTS) from the open-label group of its ongoing Phase 3 trial for Revita in weight maintenance at the American Diabetes Association meeting. These physicians who were consulted by the investment firm were all from large academic hospitals in the US. The physicians had different opinions on the mechanism behind the Revita procedure and the potential market size. However, they all agreed that controlled data is needed to fully assess the clinical profile. The physicians said the main concern is the durability of the effect. Canaccord pointed out that even conservative market share estimates from the physicians surpassed the firm's current modeling expectations. Canaccord Genuity expects Revita to reach 1% peak penetration in the weight maintenance population with a 60% probability of success. The investment firm projects that peak sales could reach $400 million in 2031. Fractyl Health, Inc. (NASDAQ:GUTS) is a metabolic therapeutics company focused on pursuing therapies that target root causes of obesity and type 2 diabetes. While we acknowledge the potential of GUTS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
Yahoo
15-07-2025
- Business
- Yahoo
BloomZ (BLMZ) and M-NEXT Team Up to Create Live Store Experiences
BloomZ Inc. (NASDAQ:BLMZ) is one of the 13 Best Japanese Stocks to Buy According to Hedge Funds. On May 22, BloomZ Inc. (NASDAQ:BLMZ) announced a business partnership with M-NEXT Holdings Co., Ltd., the parent company of O&A Co., Ltd., which operates the popular trading card specialty shop 'Ryusei no Arashi' in Japan. Through this partnership, M-NEXT and BloomZ Inc. (NASDAQ:BLMZ) will work together to create new and fun entertainment experiences for customers. The companies will combine BloomZ Inc.'s (NASDAQ:BLMZ) capabilities in planning and production through its VTuber and sound production business with M-NEXT's retail store operations capabilities. A line of eager ticket buyers outside a theatre on opening night showing the demand for live events. BloomZ Inc. (NASDAQ:BLMZ) plans to use its VTubers and voice actors to help design in-store event spaces. These spaces will be developed like open-concept radio studios where live, interactive events can be hosted. M-NEXT will also benefit as these events are designed to strengthen fan engagement and bring more traffic to the 'Ryusei no Arashi' stores. Both companies believe that this partnership will drive growth and generate new business opportunities for them. BloomZ Inc. (NASDAQ:BLMZ) is a holding company that operates BloomZ in Japan, which specializes in sound production for games and anime. BloomZ also manages, trains, and promotes voice actors and VTubers. While we acknowledge the potential of BLMZ as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
10-07-2025
- Business
- Yahoo
BofA Lowers Yum China (YUMC) PT, Keeps Buy Rating
Yum China Holdings, Inc. (NYSE:YUMC) is one of the 11 Best Food Stocks to Buy According to Wall Street Analysts. On July 7, BofA Securities reduced its price target for Yum China Holdings, Inc. (NYSE:YUMC) from $60.50 to $56.50 but kept a 'Buy' rating. The firm pointed out that Yum China Holdings, Inc. (NYSE:YUMC) has underperformed the MSCI China index by 16% since Liberation Day. This weaker performance was mainly attributed to investors reassessing the company's long-term growth after Yum China Holdings, Inc. (NYSE:YUMC) shifted its focus to smaller stores and franchising. The iconic yellow and red roof of a franchise restaurant in the bustling streets of a city. BofA's channel checks showed that Yum China Holdings, Inc.'s (NYSE:YUMC) same-store sales growth (SSSG) was around 0-1% in the second quarter. There were also indications that the performance in June might surpass expectations. BofA also observed sequential delivery order growth of over 10% in the past weekend. The research note also mentioned that Meituan and Alibaba have started offering strong delivery subsidies. These discounts could help Yum China Holdings, Inc. (NYSE:YUMC) achieve same-store sales growth in the third quarter of 2025, which is usually a busy season for the company. The research firm expects same-store sales to improve in the second half of 2025. Yum China Holdings, Inc. (NYSE:YUMC) is the largest restaurant company in China, operating more than 16,000 restaurants under 6 brands across more than 2,300 cities. The company operates and franchises restaurants under brands like KFC, Pizza Hut, and Taco Bell. While we acknowledge the potential of YUMC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
